期刊
JOURNAL OF PARKINSONS DISEASE
卷 5, 期 4, 页码 743-747出版社
IOS PRESS
DOI: 10.3233/JPD-150664
关键词
Parkinson disease; dementia; mild cognitive impairment; anticholinergics; amyloid
资金
- Parkinson's UK grant [J-0802]
- National Institute for Health Research Newcastle Biomedical Research Unit
- Biomedical Research Centre based at Newcastle Hospitals NHS Foundation Trust
- Newcastle University
- National Institute of Health Research Biomedical Research Award
- Raymond and Beverly Sackler Studentship
- Parkinson"
- s UK [J-0802, G-1507] Funding Source: researchfish
We evaluated the effect of anticholinergic burden on 219 participants with incident Parkinson's disease (PD) and 99 controls at study baseline and 18 months. Anticholinergic burden for each individual was calculated and summed according to the Anticholinergic Drug Scale (ADS). Medication with anticholinergic activity was more commonly prescribed in PD compared to controls, although mean ADS scores were not significantly different. Cognitive scores did not differ in PD participants taking medications with anticholinergic activity compared to those who were not. Low overall ADS scores due to increased awareness of adverse effects of medications and brevity of follow-up are potential explanations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据